L-Acetylleucine Completed Phase 4 Trials for Migraine

IndicationsStatusPurposePhase
CompletedNot Available4
clinicaltrials.gov IdentifierTitleDrugs
NCT01138150Ictal and Interictal Inflammatory Markers in Migraine